Sign in to continue:

Monday, May 4th, 2026

Archrock, Inc. Files Form 8-K Disclosing Annual Meeting Results and Company Information for April 30, 2026

Archrock, Inc. Reports Shareholder Meeting Results: Key Votes and Outcomes

HOUSTON, TX, May 1, 2026 – Archrock, Inc. (NYSE: AROC), a leading provider in the natural gas transmission sector, has released the results of its 2026 Annual Meeting of Stockholders held on April 30, 2026. The meeting addressed several significant proposals, all of which may hold implications for investors and the company’s future direction.

Key Highlights from the Annual Meeting

  • Election of Directors: Shareholders voted to elect the slate of directors proposed by management. The directors will serve until the next annual meeting or until their successors are elected and qualified.
    • Anne-Marie N. Ainsworth was re-elected with 142,016,289 votes for, 6,957,504 votes withheld, and 9,604,372 broker non-votes.
    • Edmund P. Segner, III was also re-elected with 142,016,289 votes for, 1,685,743 votes withheld, and 9,604,372 broker non-votes.
  • Ratification of Independent Auditors: Shareholders approved the ratification of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with a decisive majority:
    • Votes for: 151,795,016
    • Votes against: 6,678,242
    • Abstentions: 104,907
    • Broker non-votes: n/a
  • Advisory Vote on Executive Compensation: In a non-binding vote, shareholders approved the compensation for the company’s named executive officers for 2025:
    • Votes for: 142,016,289
    • Votes against: 6,957,504
    • Broker non-votes: 9,604,372

Other Notable Information

  • All proposals passed with strong shareholder support, and no new or revised financial accounting standards were adopted or opted out by the company.
  • The company confirmed that it is not an emerging growth company under SEC definition.
  • No written communications, soliciting material, or pre-commencement tender offers were disclosed in this filing, indicating no pending mergers, acquisitions, or significant corporate actions that typically affect share prices in the near term.
  • The company’s common stock (NYSE: AROC) remains listed on the New York Stock Exchange, with no changes in security registration or trading status.

Potential Market Impact

While the 2026 Annual Meeting did not reveal any immediate price-sensitive events such as mergers, acquisitions, or changes to executive leadership, the continued ratification of Deloitte & Touche LLP and the approval of executive compensation packages signal ongoing shareholder confidence in Archrock’s current leadership and strategic direction. The election and retention of experienced directors may reassure investors seeking stability in governance and oversight.

However, as all proposals were standard annual meeting items and passed with comfortable margins, there are no immediate catalysts that would be expected to significantly move the company’s share price. Investors may wish to monitor future filings for any developments regarding strategic initiatives or changes in company operations.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are encouraged to consult official filings and professional advisors before making investment decisions. No responsibility is taken for actions based on the information provided herein.

View Archrock, Inc. Historical chart here



Copart, Inc. Reports Q2 Fiscal 2026 Financial Results: Revenue and Profit Decline, Strong Cash Flow and Global Operations 1

Copart, Inc. Q2 2026 Financial Results: Key Insights for Inv...

Klaviyo, Inc. Files Form 8-K with SEC – Key Company and Stock Information (March 2, 2026)

Klaviyo, Inc. Announces \$500 Million Share Repurchase Progr...

Sionna Therapeutics 2025 Annual Report: Clinical Pipeline, Risk Factors, Intellectual Property, and Business Overview

Sionna Therapeutics, Inc. 2025 Annual Report: Key Financial ...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today